Clinical Trial Update: Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating ISB 2001 in relapsed/refractory multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ISB 2001

Snippet

Sponsor: Ichnos Sciences SA | Conditions: Relapsed/Refractory Multiple Myeloma | Phase 1 | Status: RECRUITING